auxiliar en sintesis de protenas
Increased body fat leads to elevated estrogen levels through aromatization in fat tissue, reduced insulin sensitivity, and systemic inflammation that impairs recovery
The FDAs ongoing safety communication on unapproved GLP-1 drugs used for weight loss makes clear that products not evaluated for safety, efficacy, or quality including compounded versions and those sold for research use only carry serious risks
The two clinically dominant GLP-1s are semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), typically taken as weekly injections
Whose metabolic profile fits this combination best
Our clinical team can answer any questions you have about side effects, and offer support with managing them